REPAGLINIDA HF 0.5mg tablets STADA
repaglinide Indicated for: type 2 diabetes mellitus
letter R · page 21
repaglinide Indicated for: type 2 diabetes mellitus
repaglinide Indicated for: type 2 diabetes mellitus
repaglinide Indicated for: type 2 diabetes mellitus
repaglinide Indicated for: type 2 diabetes mellitus
repaglinide Indicated for: type 2 diabetes mellitus
repaglinide Indicated for: type 2 diabetes mellitus
repaglinide Indicated for: type 2 diabetes mellitus
repaglinide Indicated for: type 2 diabetes mellitus
repaglinide Indicated for: type 2 diabetes mellitus
repaglinide Indicated for: type 2 diabetes mellitus
repaglinide Indicated for: type 2 diabetes mellitus
repaglinide Indicated for: type 2 diabetes mellitus
repaglinide Indicated for: type 2 diabetes mellitus
escin Indicated for: chronic venous insufficiency; edema
C05CXN2 Cardiovascular system | Capillary stabilizing agents | Other capillary stabilizing agents
escin Indicated for: chronic venous insufficiency; edema
C05CXN1 Cardiovascular system | Capillary stabilizing agents | Other capillary stabilizing agents
escin + diethylamine salicylate Indicated for: contusions; sprains; local inflammation; edema
C05CXN1 Cardiovascular system | Capillary stabilizing agents | Other capillary stabilizing agents
evolocumab Indicated for: dyslipidemia
levetiracetam Indicated for: epilepsy
N03AX14 Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics
levetiracetam Indicated for: epilepsy
N03AX14 Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics
levetiracetam Indicated for: epilepsy
N03AX14 Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics